Ludovico Arcuri - Concepedia

Author

Ludovico Arcuri

University of Ferrara ORCID

Also Known As

Ludovico Arcuri

Publications

432

Citations

H-Index

Concepts

All Affiliations

University of Ferrara University of Padua Institut des Maladies Neurodégénératives Novartis (Switzerland)Astraea Therapeutics (United States)

About

Ludovico Arcuri is an author at University of Ferrara specializing in neurology, medicine, and synaptic signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	98
2	Neurology	2	2	98
3	Neuroscience	1	1	29
4	Pharmacology	1	1	29
5	Molecular Neuroscience	1	1	69

Ludovico Arcuri

Publications

426

Citations

H-Index

Page 1

	Year	Citations
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex Maria Daniela Cirnaru, Antonella Marte, Elisa Belluzzi, Frontiers in Molecular Neuroscience	2014	106
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice Francesco Longo, Daniela Mercatelli, Salvatore Novello, Acta Neuropathologica Communications	2017	95
G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice Salvatore Novello, Ludovico Arcuri, Sandra Doveró, Neurobiology of Disease Neurodegenerative DiseasesMolecular NeuroscienceG2019s Lrrk2 MutationExperimental NeuropathologyDegenerative Disease	2018	69
Eltoprazine prevents levodopa‐induced dyskinesias by reducing striatal glutamate and direct pathway activity Giovanna Paolone, Alberto Brugnoli, Ludovico Arcuri, Movement Disorders	2015	55
Differential regulation of striatal motor behavior and related cellular responses by dopamine D2L and D2S isoforms Daniela Radl, Martina Chiacchiaretta, Robert G. Lewis, Proceedings of the National Academy of Sciences	2017	52
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease Ludovico Arcuri, Riccardo Viaro, Simone Bido, Neurobiology of Disease MedicineEndogenous Nociceptin/orphanin FqNeuropeptide ReceptorCell LossNeuropharmacology	2016	29
Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists Ludovico Arcuri, Salvatore Novello, Martina Frassineti, British Journal of Pharmacology	2017	20

Page 1